Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Triple therapy with fluticasone furoate, umeclidinium, and vilanterol resulted in a lower rate of moderate or severe COPD exacerbations than fluticasone furoate-vilanterol or um...